event,time
79 years old ,0
    female ,0
    admitted to the hospital ,0
    dyspnea ,-24
    palpitations ,-24
    hypertension ,-17520
    type 2 diabetes mellitus ,-17520
    atrial fibrillation ,-17520
    colonic diverticulosis ,-17520
    depressive syndrome ,-17520
    osteoporosis ,-17520
    mastectomy due to breast cancer ,-26208
    ischemic cardiomyopathy ,-17520
    acute myocardial infarction ,-17520
    percutaneous angioplasty ,-17520
    omeprazole 20 mg q.d. ,-17520
    metformin 850 mg b.i.d. ,-17520
    calcifediol 266 µg q. 1 month ,-17520
    calcium 500 mg q.d. ,-17520
    alendronate 70 mg q. 1 week ,-17520
    acenocumarol 4 mg ,-17520
    amiodarone 200 mg q.d. ,-1344
    torasemide 5 mg q.d. ,-17520
    enalapril 5 mg q.d. ,-17520
    letrozole 2.5 mg q.d. ,-17520
    citalopram 10 mg q.d. ,-17520
    acetaminophen on demand ,-17520
    lormetazepam on demand ,-17520
    pale ,0
    diaphoretic ,0
    hypothermic (35.6°C) ,0
    tachycardia (146/min) ,0
    aortic murmur II/VI ,0
    chronic venous insufficiency ,0
    no edemas ,0
    hypophonesis ,0
    crackles on the right pulmonary base ,0
    cardiac insufficiency ,0
    atrial fibrillation with fast ventricular response (150/min) ,0
    diuretics ,0
    vasodilators ,0
    digoxin ,0
    echocardiogram apical and mid-segment akinesia ,0
    hypokinesis in basal segments ,0
    elevated cardiac troponin ,0
    slight leucocytosis ,0
    increased inflammatory markers ,0
    thoracic radiography vascular redistribution ,0
    cardiomegaly ,0
    pulmonary edema ,0
    coronary angiography no stenotic or spasmodic changes ,0
    stent stenosis 30% ,0
    ventriculography apical dyskinesia ,0
    Takotsubian apical ballooning ,0
    preserved LVEF ,0
    transdermal nitrates ,0
    digoxin (added) ,0
    decrease in myocardial damage markers ,24
    electrocardiographic stability ,24
    normofrequent atrial fibrillation ,24
"    hyperthyroidism (TSH 0.014 µU/mL, FT4 4.48 ng/dL) ",120
    asymptomatic ,120
    no goiter ,120
    no exophthalmos ,120
    no pretibial myxedema ,120
    TSI <0.9 mUI/mL ,120
    anti-thyroperoxidase 6.16 UI/mL ,120
    anti-thyroglobulin 14.88 UI/mL ,120
    amiodarone for past two months ,-1344
    type I amiodarone-induced hyperthyroidism ,120
    amiodarone suspended ,120
    methimazole 10 mg q. 8 h ,120
    TSH <0.014 µU/mL ,144
    FT4 7.55 ng/dL ,144
    FT3 4.04 pg/mL ,144
    type II amiodarone-induced hyperthyroidism ,144
    prednisone 45 mg q.d. ,144
    TSH <0.014 µU/mL (after prednisone) ,168
    FT4 3.9 ng/dL ,168
    FT3 1.65 pg/mL ,168
    methimazole stopped ,168
    urgent abdominal surgery (ischemic colitis with perforation) ,168
    right hemicolectomy ,168
    descendant doses of corticoids ,168
    thyroid function normalized ,432
    discharged ,1008
    normal thyroid function ,1008
    complete resolution of TC ,1008
    cardiovascular symptoms back to baseline ,1008
    ischemic colitis with bowel perforation ,4032
    generalized sepsis ,4032
    fatal outcome ,4032
    thyroid function normal ,4032
